TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Teladoc Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$5.73+0.06 (+1.06%)
Close on Oct 19, 2026
- Market cap
- $1.04B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.80 (−32.83%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Teladoc Health, Inc. saw revenue fall 2.1% to $2.49B over the twelve months to Jun 30, 2026. Free cash flow was $253.70M, down 13.0% from a year earlier.
Revenue
$2.49B
-2.1% vs. a year earlier
Operating income
-$186.82M
TTM Q2 2026
Free cash flow
$253.70M
-13.0% vs. a year earlier
EPS, diluted
-$0.99
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.04B
- P/E ratio
- –
- Price to sales
- 0.42
- Price to book
- 0.79
- Dividend yield
- –
- Free cash flow yield
- 24.46%
Fundamentals
- Revenue
- $2.49B
- Net income
- -$177.40M
- EPS, diluted
- -$0.99
- Free cash flow
- $253.70M
- Book value per share
- $7.24
- Diluted shares
- 181M
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
$2.49B-2.1% YoY
Gross profit
$1.72B-3.9% YoY
Operating income
-$186.82M
Net income
-$177.40M
EPS, diluted
-$0.99
Free cash flow
$253.70M-13.0% YoY
Reported periodTrailing twelve months